Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Platelet count decreased? 7,491 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7,491 reports of Platelet count decreased have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 2.1% of all adverse event reports for LENALIDOMIDE.

7,491
Reports of Platelet count decreased with LENALIDOMIDE
2.1%
of all LENALIDOMIDE reports
397
Deaths
1,855
Hospitalizations

How Dangerous Is Platelet count decreased From LENALIDOMIDE?

Of the 7,491 reports, 397 (5.3%) resulted in death, 1,855 (24.8%) required hospitalization, and 138 (1.8%) were considered life-threatening.

Is Platelet count decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 7,491 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Platelet count decreased?

NIRAPARIB (4,102) ELTROMBOPAG OLAMINE (3,419) RUXOLITINIB (3,028) RITUXIMAB (2,404) VENETOCLAX (2,367) DEXAMETHASONE (2,321) PALBOCICLIB (2,277) CYCLOPHOSPHAMIDE (1,894) RIBAVIRIN (1,701) CARBOPLATIN (1,597)

Which LENALIDOMIDE Alternatives Have Lower Platelet count decreased Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Platelet count decreased Reports All Drugs Causing Platelet count decreased LENALIDOMIDE Demographics